Application of The International System for Serous Fluid Cytopathology to cerebrospinal fluid and adjunct flow cytometry analysis improves diagnostic accuracy
Cancer Cytopathology · 2026-07 · 134 (7)
DOI: 10.1002/cncy.70122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cytopathology, online erschienen am 12.06.2026. Verfasst von Minhua Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Flow Cytometry, Cerebrospinal Fluid, Cytodiagnosis, Meningeal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Departmental Research Histology Fund of Yale University School of Medicine.
Abstract (Originalsprache)
Background
Cerebrospinal fluid (CSF) is an important diagnostic tool for detecting leptomeningeal involvement by malignancy or other etiologies. Currently, there is no standardized reporting system for CSF cytology. This study aims to assess the application of The International System for Serous Fluid Cytopathology (TIS) in categorizing CSF diagnoses and the role of flow cytometry in improving diagnostic performances.
Methods
CSF cases at our institution between January 1, 2023, and December 31, 2023, were reviewed and selected slides were examined. Based on the retrospective review of cytomorphologic findings and flow cytometry results, cases were reclassified into five diagnostic categories according to TIS: nondiagnostic (ND), negative for malignancy (NFM), atypia of uncertain significance (AUS), suspicious for malignancy (SFM), and malignant (MAL).
Results
The study cohort included 854 CSF cases from 439 patients. Flow cytometry was performed in 185 (21.7%) cases with a positive result in 23 cases. After applying TIS, final cytological diagnoses included NFM (87.2%), AUS (7.1%), SFM (0.6%), and MAL (5.0%). The calculated risk of malignancy was 0.3% for NFM, 4.5% for AUS, 66.7% for SFM, and 100% for MAL. The diagnostic performance metrics were 95% sensitivity, 100% specificity, and 99% diagnostic accuracy.
Conclusions
The application of TIS to CSF specimens helps standardize reporting terminology, improves diagnostic accuracy, and offers predictive risk stratification. The conjunction with flow cytometry to CSF cytology helps reduce indeterminate diagnosis, especially for those with an uncertain etiology or prior history of hematological malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
- Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut, USA.
ORCID-Profile: Minhua Wang, Guoping Cai
Förderung
- Departmental Research Histology Fund of Yale University School of Medicine
Zitieren
APA
Wang, M., & Cai, G. (2026). Application of The International System for Serous Fluid Cytopathology to cerebrospinal fluid and adjunct flow cytometry analysis improves diagnostic accuracy. Cancer Cytopathology, 134(7). https://doi.org/10.1002/cncy.70122
Vancouver
Wang M, Cai G. Application of The International System for Serous Fluid Cytopathology to cerebrospinal fluid and adjunct flow cytometry analysis improves diagnostic accuracy. Cancer Cytopathology. 2026;134(7). doi:10.1002/cncy.70122
BibTeX
@article{Wang2026,
author = {Wang, Minhua and Cai, Guoping},
title = {Application of The International System for Serous Fluid Cytopathology to cerebrospinal fluid and adjunct flow cytometry analysis improves diagnostic accuracy},
journal = {Cancer Cytopathology},
year = {2026},
volume = {134},
number = {7},
doi = {10.1002/cncy.70122}
}
EUVIMED